Juan Montoro^1*, Ariane Boumendil^2*, Hervé Finel^3*, Stefania Bramanti^4*, Luca Castagna Sr.^5*, Didier Blaise, MD, PhD⁶, Alida Dominietto, MD^7*, Aleksandr Kulagin Sr.^8*, Ibrahim Yakoub-Agha, MD, PhD^9*, Abdelghani Tbakhi, MD^10*, Carlos Solano, MD, PhD¹¹, Sebastian Giebel^12*, Zafer Gulbas, MD^13*, Dolores Caballero^14*, Jose A. Perez-Simon, MD, PhD^15*, Jose Luis Diez Martin^16*, Paolo Corradini, MD¹⁷, Yener Koc, MD¹⁸, Gerard Socié¹⁹, Mutlu Arat²⁰, Manuel Jurado, MD, PhD²¹, Arancha Bermudez^22*, Hélène Labussière-Wallet^23*, Marta Villalba^24*, Fabio Ciceri^25*, Montserrat Rovira, MD^26*, Arnon Nagler, MD²⁷, Anna Maria Sureda Balari, MD, PhD²⁸ and Bertram Glass, MD^29*

¹Hematology Department, Hospital La Fe, Valencia, Spain
²EBMT Lymphoma Working Party, Paris Office, Paris, FRA
³European Society for Blood and Marrow Transplantation, Paris, France
⁴Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
⁵Istituto Clinico Humanitas, Rozzano Milano, Italy, Palermo, ITA
⁶Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
⁷IRCCS Ospedale Policlinico San Martino, Genoa, Italy
⁸b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
⁹CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
¹⁰King Hussein Cancer Centre, Amman, JOR
¹¹Hematology Department, Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
¹²Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
¹³Anadolu Health Center Affiliated John Hopkins, Kocaeli, Gebze, TUR
¹⁴Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain
¹⁵Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla., Sevilla, Spain
¹⁶Hospital Gregorio Marañon, Madrid, ESP
¹⁷University of Milan and Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
¹⁸MEDICAL PARK HOSPITALS, Beylikduzu, Istanbul, TUR
¹⁹Hopital St. Louis, Department of Hematology - BMT, Paris, France
²⁰İstanbul Florence Nightingale Hospital, Hematology Department, İstanbul, Turkey
²¹Hospital Virgen De Las Nieves, Granada, ESP
²²Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
²³Centre Hospitalier Lyon Sud, Lyon, France
²⁴Hospital Universitario y Politecnico La Fe, Valencia, ESP
²⁵University Vita-Salute, IRCCS Ospedale San Raffaele, Haematology and BMT, Milan, Italy
²⁶Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
²⁷Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
²⁸Institut Catala D'Oncologia, Barcelona, Spain
²⁹Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St. Georg, Hamburg, Germany

Thomas Heinicke, MD^1*, Myriam Labopin^2*, Didier Blaise, MD, PhD³, Jaime Sanz, MD, PhD^4*, Ibrahim Yakoub-Agha, MD, PhD^5*, Thomas Cluzeau, MD, PhD⁶, Marco Ladetto⁷, Jürgen Finke, MD⁸, Eric Deconinck⁹, Jurjen Versluis, MD, PhD^10*, Urpu Salmenniemi^11*, Andreas Neubauer, MD¹², Eolia Brissot^13*, Ali Bazarbachi, MD, PhD¹⁴, Arnon Nagler, MD¹⁵, Jordi Esteve, MD, PhD¹⁶, Fabio Ciceri^17* and Mohamad Mohty, MD, PhD¹⁸

¹Department of Hematology and Oncology, University Hospital Magdeburg, Magdeburg, Sachsen-Anhalt, Germany
²EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
³Institut Paoli Calmettes, Marseille, FRA
⁴Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, España, Valencia, Spain
⁵CHU de Lille, Université de Lille, INSERM U1286, Infinite, 59000, Lille, France
⁶Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
⁷Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
⁸Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁹Besançon University Hospital, Besançon, France
¹⁰Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands
¹¹Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
¹²Philipps University, Marburg, DEU
¹³Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
¹⁴American University of Beirut Dept. of Medicine, Beirut, Lebanon
¹⁵Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel
¹⁶Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
¹⁷Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
¹⁸department of hematology and cell therapy, hopital Saint-Antoine, EBMT Acute Leukemia Working Party and Registry, Hospital Saint-Antoine, Paris University, Paris, France

Sandra Cohen, MD¹, Myriam Labopin^2*, Nadia M. Bambace, MD³, Imran Ahmad, MD⁴, Maude Dumont-Lagacé^5*, Fabio Ciceri^6*, Donal P McLornan, MD, PhD^7*, Hélène Labussière-Wallet^8*, Nicolaus Kröger, MD^9*, Regis Peffault De Latour^10*, Yves Chalandon, MD¹¹, Edouard Forcade, MD, PhD^12*, Thomas Cluzeau, MD, PhD¹³, Pavel Jindra^14*, Aleksandr Kulagin Sr.^15*, Jean Roy, MD¹⁶, Sylvie Lachance, MD¹⁷, Frederic Barabe, MD¹⁸, Pierre Caudrelier^19*, Ibrahim Yakoub-Agha, MD, PhD^20* and Mohamad Mohty, MD, PhD²¹

¹Hôpital Maisonneuve-Rosemont, Université de Montréal, Institut Universitaire d'Hémato-Oncologie et de Thérapie cellulaire, Montreal, QC, Canada
²EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
³Baptist Health South Florida, Miami Cancer Institute, Miami, FL
⁴Hematology-Oncology and Cell Therapy University Institute, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC, CAN
⁵Excellthera, MontréAl, QC, CAN
⁶Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
⁷Department of Haematology, University College London Hospitals NHS Trust, London, ENG, United Kingdom
⁸Hôpital Lyon Sud, Pierre Bénite, France
⁹University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
¹⁰Hôpital Saint-Louis,, Paris, France
¹¹Univ. Hospital of Geneva, Geneva, Switzerland
¹²Department of Hematology, Bordeaux University Hospital, Bordeaux, France
¹³Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
¹⁴Dpt. of Hemato-oncology, University Hospital Pilsen and Charles University, Pilsen, Czech Republic
¹⁵b. First State Pavlov Medical University of St. Petersburg, Raisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Hematology, and Transplantation, St-Petersburg, Russia, St. Petersburg, RUS
¹⁶Maisonneuve-Rosemont Hosp., Montreal, QC, CAN
¹⁷Hopital Maisonneuve Rosemont, Institut Universitaire d'Hémato-Oncologie Greffe et Thérapie Cellulaire, Montreal, QC, CAN
¹⁸Hôpital de l'Enfant-Jésus, Division of Hematology and Medical Oncology, CHU de Québec - Université Laval, Québec, QC, Canada
¹⁹ExCellThera, Montréal, QC, Canada
²⁰CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, LILLE, FRA
²¹Hôpital Saint Antoine, Paris, FRA

Mahasweta Gooptu, MD¹, Haesook T. Kim, PhD², Kaina Chen^1*, Ann Mullally, MD³, Joseph Antin, MD^1*, Corey Cutler¹, Amar H Kelkar, MD¹, John Koreth, MD, MBBS, PhD, DPhil¹, Roman M. Shapiro, MD¹, Robert J. Soiffer, MD¹, Daniel J. DeAngelo⁴, Jacqueline S. Garcia, MD⁵, Marlise R. Luskin, MD⁴, Richard M Stone, MD¹, Martha Wadleigh, MD¹, Eric S. Winer, MD¹, R. Coleman Lindsley⁶ and Vincent Ho, MD^1*

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁶Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA

Oren Pasvolsky, MD^1*, Shai Shimony, MD^2*, Rima M. Saliba, PhD^1*, Celina Ledesma^1*, Gabriela Rondon, MD³, Priti Tewari, MD^4*, Dristhi Ragoonanan, MBBS⁵, Nicholas J. Short, MD⁶, Elias Jabbour⁷, Mahasweta Gooptu, MD⁸, Vincent T. Ho, MD^9*, Robert J. Soiffer, MD¹⁰, Joseph Antin, MD^10*, John Koreth, MD, MBBS, PhD, DPhil¹⁰, Corey Cutler¹⁰, Jonathan Paolino, MD¹¹, Christine Duncan, MD¹², Leslie E. Lehmann¹³, Daniel J. DeAngelo, MD¹⁴, Hagop M. Kantarjian, MD⁶, Richard E. Champlin, MD⁴, Elizabeth J. Shpall, MD¹, Marlise R. Luskin, MD¹⁴ and Partow Kebriaei, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³University f Texas MD Anderson Cancer Center, Houston, TX
⁴MD Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁸Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA
⁹Stem Cell Transplantation, Harvard Medical School, Boston, MA
¹⁰Dana-Farber Cancer Institute, Boston, MA
¹¹Dana Farber Cancer Institute, Boston, MA
¹²Division of Pediatric Hematology/Oncology, Boston Children’s Hospital, Boston, MA
¹³Dana-Farber Cancer Institute, Inc., Boston, MA
¹⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Tariq Kewan, MBBChir¹, Jan Philipp Bewersdorf, MD², Ondrej Blaha, PhD^3*, Maximilian Stahl, MD⁴, Najla H Al Ali, MS^5*, Amy E. DeZern, MD, MHS⁶, Mikkael A. Sekeres, MD⁷, Geoffrey L Uy, MD⁸, Hetty E. Carraway, MD, MBA⁹, Pinkal Desai, MD, MPH¹⁰, Elizabeth A. Griffiths, MD¹¹, Eytan M. Stein¹², Andrew M. Brunner, MD¹³, Maria L Amaya, MD, PhD¹⁴, Joshua F. Zeidner, MD¹⁵, Michael R. Savona, MD¹⁶, Jessica M. Stempel, MD¹⁷, Namrata Sonia Chandhok, MD¹⁸, Constantine Logothetis, MD¹⁹, Hunter Cochran, MD²⁰, Ameera Rose^21*, Gail J. Roboz, MD²², Eunice S. Wang, MD²³, Benjamin Rolles, MD²⁴, Amyah C. Harris^25*, Rory M. Shallis, MD²⁶, Zhuoer Xie, MD, MS²⁷, Eric Padron, MD⁵, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP²⁸, David A Sallman, MD²⁹, Matteo Giovanni Della Porta, MD^30*, Rami S. Komrokji, MD⁵ and Amer M. Zeidan, MBBS, MHS¹⁷

¹Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
²Memorial Sloan Kettering Cancer Center, New York, NY
³Yale Cancer Center, Yale University, New Haven
⁴Dana Farber Institute, Boston, MA
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶Sidney Kimmel CCC, Johns Hopkins University, Baltimore, MD
⁷Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁸Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁹Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
¹⁰Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
¹¹Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹²Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁴Division of Hematology, University of Colorado, Aurora, CO
¹⁵University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
¹⁶Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
¹⁷Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT
¹⁸University of Miami, Miami, FL
¹⁹Washington University, Saint Louis, MO
²⁰Washington University in St. Louis, Saint Louis, MO
²¹Cleveland Clinic, Cleveland, OH
²²Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY
²³Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²⁴Division of Hematology, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
²⁵Dana Farber Cancer Institute, Boston, MA
²⁶Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Killingworth, CT
²⁷H. Lee Moffitt Cancer Institute, Tampa, FL
²⁸Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²⁹H. Lee Moffitt Cancer Center, Tampa, FL
³⁰Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy

Ibrahim Aldoss, MD^1,2, Haoyue Shan, MS^3*, Dongyun Yang, PhD^4*, Mary C Clark, PhD^5*, Monzr M. Al Malki, MD⁶, Ahmed Aribi, MD^7*, Karamjeet S. Sandhu, MD⁷, Amandeep Salhotra, MD², Vaibhav Agrawal, M.D.⁸, Hoda Pourhassan, MD⁸, Paul B. Koller, MD⁷, Haris Ali, MD⁹, Andrew Artz, MD, MS⁸, Idoroenyi Amanam, MD⁹, Nicole Karras, MD^8*, Anna Pawlowska, MD¹⁰, Lindsey Murphy, MD^8*, Joycelynne Michelle Palmer, PhD^8*, Guido Marcucci, MD⁹, Anthony Stein, MD¹¹, Vinod Pullarkat, MD¹², Ryotaro Nakamura, MD¹³ and Stephen J. Forman, MD, FACP¹⁴

¹Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Department of Comuputational and Quantitative Medicine, City of Hope, Duarte, CA
⁴Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
⁵Department of Clinical and Translational Project Development, City of Hope, Duarte, CA
⁶National Medical Center, City of Hope, Duarte, CA
⁷Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁸City of Hope, Duarte, CA
⁹Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
¹⁰City of Hope National Med. Ctr., Duarte, CA
¹¹City of Hope Cancer Center, Duarte, CA
¹²Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA
¹³Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA
¹⁴Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Mari Morita-Fujita, MD^1,2*, Takero Shindo, MD, PhD^3*, Shuji Kawaguchi, PhD^2*, Kiyotaka Izumi, MD, PhD^1*, Yuichi Inadomi, PhD^2*, Masakazu Shimizu, PhD^2*, Ai Murano^2*, Akiyo Morinibu^2*, Meiko Takahashi, PhD^2*, Junya Kanda, MD, PhD^1*, Taro Tsujimura, PhD^4*, Takuya Yamamoto, PhD^4*, Koji Kato, M.D., Ph.D.⁵, Hidenori Tanaka, PhD^6*, Nobuaki Nakano, M.D.^7*, Tetsuya Eto, MD, PhD^8*, Yasuhiko Miyazaki, MD, PhD^9*, Kazunori Imada, MD, PhD^10*, Youko Suehiro, MD, PhD^11*, Toshiro Kawakita, MD, PhD^12*, Tatsuo Ichinohe, MD, PhD^13*, Takahiro Fukuda, MD, PhD^14*, Makoto Onizuka, MD, PhD¹⁵, Yoshiko Atsuta, MD, PhD^16*, Fumihiko Matsuda, PhD^2* and Akifumi Takaori-Kondo, MD, PhD³

¹Department of Hematology / Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan
²Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
³Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁴Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
⁵Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
⁶HLA Foundation Laboratory, Kyoto, Japan
⁷Department of Hematology, Imamura General Hospital, Kagoshima, Japan
⁸Department of Hematology, Hamanomachi Hospital, Fukuoka, JPN
⁹Department of Hematology, Oita Prefectural Hospital, Oita, JPN
¹⁰Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan
¹¹Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
¹²Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
¹³Department of Hematology and Oncology, Research Institute For Radiation Biology and Medicine, Hiroshima University, Hiroshima, JPN
¹⁴Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
¹⁵Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
¹⁶Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan

Himil Mahadevia, MBBS¹, Liuyan Jiang, MD^2*, Zhuo Li^3*, Hemant S. Murthy, MD⁴, James M. Foran, MD⁵, Vivek Roy, MD⁶, Ernesto Ayala, MD⁴, Mohamed A. Kharfan-Dabaja, MD, MBA⁴ and Madiha Iqbal, MD⁴

¹Department of Internal Medicine, University of Missouri at Kansas City, Kansas City, MO
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville
³Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville
⁴Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
⁵Division of Hematology & Medical Oncology, Mayo Clinic Florida, Jacksonville, FL
⁶Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL

Scott R. Solomon, MD¹, Michael T Aubrey^2*, Xu Zhang, PhD^3*, Lizamarie Bachier-Rodriguez, MD^1*, Lawrence Morris, MD¹, H. Kent Holland, MD^1*, Christina Roark^2*, Katelin C Jackson^1*, Asad Bashey, MD, PhD¹ and Melhem M. Solh, MD¹

¹Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
²University of Colorado Cord Blood Bank & Clinimmune Lab, Aurora, CO
³Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Hidehiro Itonaga, MD, PhD^1,2, Yasushi Miyazaki, MD PhD³, Machiko Fujioka, MD^4*, Ken Ishiyama, MD, PhD⁵, Jun Aoki, MD, PhD^6*, Noriko Doki, MD, PhD⁷, Tetsuya Nishida, MD, PhD^8*, Takahiro Fukuda, MD, PhD^9*, Naoyuki Uchida, MD, PhD¹⁰, Yasunori Ueda, MD, PhD¹¹, Yasufumi Uehara^12*, Yuta Katayama, MD, PhD¹³, Makoto Onizuka, MD, PhD¹⁴, Tatsuo Ichinohe, M.D.Ph.D.¹⁵ and Yoshiko Atsuta, MD, PhD^16*

¹Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan
²Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki city, NSK, Japan
³Nagasaki University, Nagasaki, Japan
⁴Department of Hematology, Sasebo City General Hospital, Sasebo, NSK, JPN
⁵Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan
⁶Department of Hematology, Kanto Rosai Hospital, Kawasaki, Japan
⁷Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
⁸Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan
⁹Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
¹⁰Department of Hematology, Toranomon Hospital, Tokyo, Japan
¹¹Department of Hematology/Oncology, Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan
¹²Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan
¹³Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan
¹⁴Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan
¹⁵Research Institute For Radiation Biology and Medicine, Hiroshima, Japan
¹⁶Japanese Data Center For Hematopoietic Cell Transplantation, Nagakute, Japan

Lin Li^1*, Yishan Ye, MD^2*, Jacques-Emmanuel Galimard^3*, Myriam Labopin^4*, Depei Wu, M.D.⁵, Jia Chen, M.D.^6*, Nicolaus Kröger, MD^7*, Jakob Passweg Sr.^8*, Urpu Salmenniemi^9*, Maija Itäla-remes, MD, PhD^10*, Xavier Poiré, MD, PhD^11*, Matthias Eder^12*, Johan Maertens^13*, David Burns, MD, PhD^14*, Henrik Sengeloev^15*, Gitte Olesen, MD, PhD^16*, Didier Blaise, MD, PhD¹⁷, Jürgen Finke, MD¹⁸, Alain Gadisseur, MD, PhD^19*, Ali Bazarbachi, MD, PhD²⁰, Eolia Brissot^3,21*, Arnon Nagler^22*, Yi Luo²³, Jimin Shi^24*, Fabio Ciceri^25*, Mohamad Mohty, MD, PhD^26,27, He Huang^24* and Norbert Claude Gorin Sr.^3,28

¹The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Paris, France
³EBMT Paris Office, Hôpital Saint Antoine, Paris, France
⁴EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
⁵The First Affiliated Hospital of Soochow University, SUZHOU, China
⁶National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁷University Medical Center Hamburg, Hamburg, Germany
⁸University Hospital | Basel, Basel, Switzerland
⁹Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
¹⁰Department of Clinical Haematology and Stem Cell Transplant Unit, University Hospital Turku, Turku, Finland
¹¹Section of hematology, Institut Roi Albert II, Cliniques Universitaires St-Luc, Brussels, Belgium
¹²Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹³University Hospital Gasthuisberg, Leuven, Belgium
¹⁴University Hospital Birmingham NHS Trust, Stoke, United Kingdom
¹⁵Rigshospitalet, Copenhagen, Denmark
¹⁶Aarhus University Hospital, Aarhus, Denmark
¹⁷Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
¹⁸University of Freiburg, Dept. of Medicine-Hematology, Oncology, Freiburg, Germany
¹⁹Antwerp University Hospital, Edegem, Belgium
²⁰American University of Beirut Dept. of Medicine, Beirut, Lebanon
²¹Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris, France
²²Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
²³The First Affiliated Hospital, Zhejiang Unibersity School of Medicine, Hangzhou, China
²⁴Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²⁵Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
²⁶Department of Hematology and Cell Therapy, EBMT Paris study office, Saint Antoine Hospital, Paris, France
²⁷Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France
²⁸Department of Hematology and Cell therapy, Hospital Saint-Antoine, Sorbonne University, Paris, France

Nour Moukalled, MD^1*, Myriam Labopin^2*, Jurjen Versluis, MD, PhD^3*, Gerard Socié⁴, Didier Blaise^5*, Urpu Salmenniemi^6*, Alessandro Rambaldi, M.D.⁷, Tobias Gedde-Dahl, MD^8*, Eleni Tholouli, MD^9*, Nicolaus Kröger, MD^10*, Jean-Henri Bourhis, MD, PhD¹¹, Peter A. Von Dem Borne, MD, PhD^12*, Etienne Daguindau, MD^13*, Édouard Forcade^14*, Arnon Nagler^15*, Jordi Esteve, MD, PhD¹⁶, Fabio Ciceri^17*, Ali Bazarbachi, MD, PhD¹⁸ and Mohamad Mohty, MD, PhD¹⁹

¹Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
²EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
³Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands
⁴Hopital St. Louis, Department of Hematology - BMT, Paris, France
⁵Programme de Transplantation & Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France
⁶Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
⁷Hematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁸Oslo University Hospital, Rikshospitalet, Clinic for Cancer Medicine, Hematology Department, Section for Stem Cell Transplantation, Oslo, Norway
⁹Manchester Royal Infirmary, Clinical Haematology Department, Manchester, United Kingdom
¹⁰University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
¹¹BMT Service, Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
¹²Hematology, Leiden University Medical Center, Leiden, Netherlands
¹³Department of Clinical Hematology, Hopital Jean Minjoz, Service d`Hématologie, Besançon, France
¹⁴Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France
¹⁵Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel
¹⁶Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain
¹⁷University Vita-Salute, IRCCS Ospedale San Raffaele, Haematology and BMT, Milan, Italy
¹⁸American University of Beirut Dept. of Medicine, Beirut, Lebanon
¹⁹Saint-Antoine Hospital, Sorbonne University, Paris, France

Muzaffar H. Qazilbash, MD¹, Hina N. Khan, MD^1,2, Denái R. Milton, MS^3*, Oren Pasvolsky, MD^1,4,5*, Mark R. Tanner, PhD^1*, Uday R. Popat, MD¹, Partow Kebriaei, MD¹, Chitra Hosing, MD¹, Issa F. Khouri, MD¹, Katy Rezvani, MD⁶, Yago Nieto, MD, PhD¹, Betul Oran, MD, MS^1*, Samer A. Srour, MD¹, Neeraj Y. Saini, MD¹, Amanda L. Olson, MD¹, Sairah Ahmed, MD^1,7, Gheath Alatrash, PhD, DO¹, Gabriela Rondon, MD¹, Marina Y. Konopleva⁸, Richard E. Champlin, MD¹, Elizabeth J. Shpall, MD¹, Qaiser Bashir, MD¹ and Naveen Pemmaraju, MD⁸

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematology and Oncology, The University of Texas Health Science Center McGovern Medical School, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
⁶Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Aya Nishida, MD^1*, Otoya Watanabe, MD^1*, Daisuke Kaji, MD, PhD^1*, Yuki Taya, MD, PhD^1*, Shinsuke Takagi, MD, PhD^1*, Hisashi Yamamoto, MD, PhD^1*, Go Yamamoto, MD, PhD^1*, Yuki Asano-Mori², Atsushi Wake, MD, PhD³ and Naoyuki Uchida, MD, PhD¹

¹Department of Hematology, Toranomon Hospital, Tokyo, Japan
²Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan
³Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan

Chika Kato^1*, Yuho Najima, MD, PhD², Daichi Sadato, PhD^3*, Chizuko Hirama^3*, Kana Kato, MD^4*, Kaori Kondo, MD^4*, Yasutaka Sadaga^4*, Satoshi Sakai, MD^4*, Yasuhiro Kambara, MD^4*, Yoshimi Nabe, MD^4*, Ko Teshima, MD^4*, Kazuya Asano, MD^4*, Kazuya Kurihara, MD^4*, Atsushi Jinguji, MD^4*, Masashi Shimabukuro, MD^4*, Fumihiko Ouchi, MD^4*, Kazuki Inai, MD^4*, Satoshi Koi, MD^4*, Naoki Shingai, MD, PhD^4*, Takashi Toya, MD, PhD^4*, Hiroaki Shimizu, MD, PhD⁴, Kyoko Haraguchi, MD, PhD^5*, Takeshi Kobayashi, MD, PhD^4*, Hironori Harada, MD, PhD^4,6, Yoshiki Okuyama, MD, PhD^5*, Yuka Harada, MD, PhD³ and Noriko Doki, MD, PhD⁴

¹Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-Ku, Japan
²Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, TKY, Japan
³Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
⁴Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
⁵Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
⁶Lab. Oncology, Tokyo University of Pharmacy & Life Sciences, Tokyo, Japan

Xiaohui Hu^1*, Depei Wu^1,2,3, Suning Chen^4*, Yaxue Wu^5*, Yang Zhang^6*, Lian Bai^6*, Bing Wu^7*, Haixia Zhou^1*, Mingzhu Xu^1*, Shanshan Jiang^8*, Chongsheng Qian^1* and Shengli Xue^1*

¹Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
²National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
³The First Affiliated Hospital of Soochow University, Suzhou, China
⁴National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
⁵Soochow Hopes Hematology Hospital, Suzhou, AL, China
⁶Canglang Hospital of Suzhou, Suzhou, China
⁷Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China
⁸Soochow Hopes Hematology Hospital, Suzhou, China

Jaap Jan Boelens, MD¹, Andrew Bodiford, PharmD^2*, Francois Bourhis, MSc^3*, Marie Baccara-Dinet, MD, MSc^4*, Lauren Rota, PhD^5* and Michaela Lysikova, MD, PhD^6*

¹Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
²Sanofi, Bridgewater, Bridgewater, MA
³Sanofi, Chilly-Mazarin, France
⁴Sanofi, Montpellier, France
⁵Sanofi, Bridgewater
⁶Sanofi, s.r.o, Czech Republic

Kohei Ishigiwa^*, Takanobu Morshita, MD, PhD^*, Yuri Uno, MD^*, Atsushi Kubo, MD^*, Norie Nakatani, MD^*, Tomoki Naito, MD^*, Yosuke Domon, MD^*, Syo Fukuoka, MD^*, Yusuke Kagaya, MD^*, Tatsunori Goto, MD, PhD^* and Tetsuya Nishida, MD, PhD^*

Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan